Sanofi India last traded at ₹2,932.70 (2026-10-13). Over the past month the stock moved -5.7%, three months the stock moved -8.3%, year the stock moved -41.8%. Its closing range over 52 weeks is ₹2,929.00 – ₹4,780.60, with the latest close 38.7% below the high.
Closing prices up to 2026-10-13.
Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of medicines for therapy areas such as Diabetes, Cardiology, Thrombosis, Central Nervous System and Anti-histamines.[1]
Parent Company:[1] Sanofi Global and its 100% subsidiary - Hoechst GmbH, are the shareholders of Sanofi India and together hold 60.40%. Company's follows parent company's financial year hence, Financial year is same as Calender Year.
In the latest quarter (Jun 2026), Sanofi India reported sales of ₹438.00 crore (+7.9%) and net profit of ₹84.00 crore (+20.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 438.00 | 115.00 | 26.00 | 84.00 | 36.30 |
| Mar 2026 | 472.00 | 143.00 | 30.00 | 103.00 | 44.61 |
| Dec 2025 | 420.00 | 90.00 | 22.00 | 62.00 | 26.83 |
| Sep 2025 | 475.00 | 134.00 | 28.00 | 76.00 | 33.04 |
| Jun 2025 | 406.00 | 95.00 | 23.00 | 70.00 | 30.22 |
| Mar 2025 | 536.00 | 172.00 | 32.00 | 120.00 | 51.96 |
| Dec 2024 | 515.00 | 118.00 | 23.00 | 91.00 | 39.70 |
| Sep 2024 | 524.00 | 120.00 | 23.00 | 82.00 | 35.74 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +6.7% | +9.8% | +4.9% | -12.5% | -9.4% | -18.4% | -11.9% | +7.9% |
| Operating profit growth | +5.3% | +18.0% | +25.5% | -18.1% | +11.7% | -23.7% | -16.9% | +21.1% |
| Net profit growth | -46.1% | -34.1% | -12.4% | -32.0% | -7.3% | -31.9% | -14.2% | +20.0% |
| EPS growth | -46.0% | -33.7% | -12.5% | -32.8% | -7.6% | -32.4% | -14.1% | +20.1% |
| OPM % | 23.0% | 23.0% | 32.0% | 23.0% | 28.0% | 22.0% | 30.0% | 26.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Dec 2025), Sanofi India reported sales of ₹1,837.00 crore (-8.7%) and net profit of ₹327.00 crore (-21.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Dec 2025 | 1,837 | 491.00 | 27.00 | 327.00 | 142.04 |
| Dec 2024 | 2,013 | 491.00 | 24.00 | 414.00 | 179.78 |
| Dec 2023 | 1,996 | 488.00 | 24.00 | 603.00 | 262.26 |
| Dec 2022 | 2,770 | 704.00 | 25.00 | 621.00 | 269.83 |
| Dec 2021 | 2,957 | 762.00 | 26.00 | 944.00 | 410.61 |
| Dec 2020 | 2,902 | 716.00 | 25.00 | 478.00 | 207.65 |
| Dec 2019 | 3,071 | 667.00 | 22.00 | 414.00 | 180.09 |
| Dec 2018 | 2,771 | 625.00 | 23.00 | 381.00 | 165.48 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +12.6% | +10.8% | -5.5% | +1.9% | -6.3% | -27.9% | +0.9% | -8.7% |
| Operating profit growth | +16.2% | +6.7% | +7.3% | +6.4% | -7.6% | -30.7% | +0.6% | +0.0% |
| Net profit growth | +16.9% | +8.7% | +15.5% | +97.5% | -34.2% | -2.9% | -31.3% | -21.0% |
| EPS growth | +16.7% | +8.8% | +15.3% | +97.7% | -34.3% | -2.8% | -31.4% | -21.0% |
| OPM % | 23.0% | 22.0% | 25.0% | 26.0% | 25.0% | 24.0% | 24.0% | 27.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Sanofi India.
Get Free AI Stock Analysis FREE →Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 crore - ETPharma.com
Sanofi Consumer Healthcare closes trading window from Oct 1 for Q2FY27 results - scanx.trade
Sanofi Consumer Healthcare closes trading window from Oct 1 for Q2FY27 results - scanx.trade
Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 crore - ETPharma.com
Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 crore - ETPharma.com
Sanofi India receives Rs 23.74 crore GST show cause notice - Business Standard
Sanofi India receives Rs 23.74 crore GST show cause notice - Business Standard
Sanofi India receives Rs 23.74 crore GST show cause notice - Business Standard
Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 cr
Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 cr
Sanofi India shares were last quoted at ₹2,932.70 (-0.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Sanofi India has a price-to-earnings (P/E) ratio of 17.50 and a price-to-book (P/B) ratio of 9.43. The industry P/E is 53.33.
The 52-week high of Sanofi India is ₹4,896.00 and the 52-week low is ₹3,050.00.
The market capitalisation of Sanofi India is about ₹7,231.39 crore.
In the latest quarter (Jun 2026), Sanofi India reported sales of ₹438.00 crore (+7.9%) and net profit of ₹84.00 crore (+20.0%), compared with the same quarter last year.
Promoters hold about 60.40% of Sanofi India.
Sanofi India belongs to the Pharmaceuticals & Drugs sector.